Document Detail


The CroRS two-component regulatory system is required for intrinsic beta-lactam resistance in Enterococcus faecalis.
MedLine Citation:
PMID:  14645279     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Enterococcus faecalis produces a specific penicillin-binding protein (PBP5) that mediates high-level resistance to the cephalosporin class of beta-lactam antibiotics. Deletion of a locus encoding a previously uncharacterized two-component regulatory system of E. faecalis (croRS) led to a 4,000-fold reduction in the MIC of the expanded-spectrum cephalosporin ceftriaxone. The cytoplasmic domain of the sensor kinase (CroS) was purified and shown to catalyze ATP-dependent autophosphorylation followed by transfer of the phosphate to the mated response regulator (CroR). The croR and croS genes were cotranscribed from a promoter (croRp) located in the rrnC-croR intergenic region. A putative seryl-tRNA synthetase gene (serS) located immediately downstream from croS did not appear to be a target of CroRS regulation or to play a role in ceftriaxone resistance. A plasmid-borne croRp-lacZ fusion was trans-activated by the CroRS system in response to the presence of ceftriaxone in the culture medium. The fusion was also induced by representatives of other classes of beta-lactam antibiotics and by inhibitors of early and late steps of peptidoglycan synthesis. The croRS null mutant produced PBP5, and expression of an additional copy of pbp5 under the control of a heterologous promoter did not restore ceftriaxone resistance. Deletion of croRS was not associated with any defect in the synthesis of the nucleotide precursor UDP-MurNAc-pentapeptide or of the D-Ala(4)-->L-Ala-L-Ala-Lys(3) peptidoglycan cross-bridge. Thus, the croRS mutant was susceptible to ceftriaxone despite the production of PBP5 and the synthesis of wild-type peptidoglycan precursors. These observations constitute the first description of regulatory genes essential for PBP5-mediated beta-lactam resistance in enterococci.
Authors:
Yannick Comenge; Richard Quintiliani; Ling Li; Lionnel Dubost; Jean-Paul Brouard; Jean-Emmanuel Hugonnet; Michel Arthur
Related Documents :
10952599 - Concentration-dependent selection of small phenotypic differences in tem beta-lactamase...
10647079 - Decreased production of ampc-type beta-lactamases associated with the development of re...
19802979 - Influence of bacterial beta-lactamase production on susceptibility in agar or broth to ...
2689349 - Extended broad spectrum beta-lactamase in klebsiella pneumoniae including resistance to...
6703679 - Effect of temocillin in combination with other beta-lactam antibiotics.
10660499 - Long-term trends in susceptibility of moraxella catarrhalis: a population analysis.
20673269 - Epidemiology of methicillin-susceptible staphylococcus aureus lineages in five major af...
10761729 - Antibiotics for prophylaxis of plasmodium falciparum infections: in vitro activity of d...
22808809 - Aspergillus species in clinical specimen: a seven year prevalence study from eastern ne...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of bacteriology     Volume:  185     ISSN:  0021-9193     ISO Abbreviation:  J. Bacteriol.     Publication Date:  2003 Dec 
Date Detail:
Created Date:  2003-12-03     Completed Date:  2004-01-07     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  2985120R     Medline TA:  J Bacteriol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  7184-92     Citation Subset:  IM    
Affiliation:
INSERM E0004-LRMA, UFR Broussais-Hôtel Dieu, Université Paris VI, 75270 Paris, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Bacterial Agents / pharmacology
Bacterial Proteins / chemistry,  genetics,  metabolism
Carbohydrate Sequence
Ceftriaxone / pharmacology
Chromosome Mapping
Cytoplasm / metabolism
Enterococcus faecalis / drug effects*,  genetics*,  metabolism
Gene Deletion
Molecular Sequence Data
Peptidoglycan / metabolism
Promoter Regions, Genetic
RNA, Messenger
beta-Lactam Resistance / physiology*
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents; 0/Bacterial Proteins; 0/Peptidoglycan; 0/RNA, Messenger; 73384-59-5/Ceftriaxone
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Competence-induced cells of Streptococcus pneumoniae lyse competence-deficient cells of the same str...
Next Document:  A new pathway for salvaging the coenzyme B12 precursor cobinamide in archaea requires cobinamide-pho...